4
Changes in Ownership
Eloxx Pharmaceuticals, Inc. Filed Acc 0001144204-12-063597
Options or other derivatives
- Director acquired 210,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Isabelle Warren John · Director
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2012-11-16 | Grant or award : show line 1 in the form Common Stock Option | +210,000 | $0.17 | 2022-11-16 | 2,100,000 | 490,000 | D |
Loading xslF345X03/form454599_20121116054220-.xml…